JSE:DCP Long ideaJSE:DCP Ascending triangle setup is in play. Decent R/R if price retests ATH. Still looking for a close >3150 for long.
1ZAR
1.00 BZAR
32.66 BZAR
431.24 M
About DIS-CHEM PHARMACIES LTD
Sector
Industry
CEO
Rui Manuel Morais
Website
Headquarters
Midrand
Employees (FY)
20.5 K
Founded
1978
ISIN
ZAE000227831
FIGI
BBG00F0RB5H4
Dis-Chem Pharmacies Ltd. manufactures and retails pharmaceutical products. It operates through the Retail; and Wholesale segments. The Retail segment consists of Dis-Chem stores, retailers of pharmaceutical and a variety of health and beauty products, as well as pharma-logistic services and oncology and retailers of pharmaceutical products. The Wholesale segment refers to the CJ Wholesale and Dis-Chem Distribution businesses, wholesalers of pharmaceutical and a variety of health and beauty products. The company was founded by Ivan Leon Saltzman and Lynette Frances Saltzman in 1978 and is headquartered in Midrand, South Africa.
Our opinion on the current state of DCPDis-Chem Pharmacies, listed since November 2016, directly competes with Clicks in the pharmaceutical, medicine, and beauty products markets. Originally a family business controlled by the Saltzman family through Ivlyn, it saw a significant change in August 2021 when Ivlyn sold a portion of its stake
$JSEDCP - Dischem: Great Run, But I Count Five WavesSee link below for previous analysis.
Dischem has had a stellar run from the 2154 low, tracing out a textbook five wave advance.
Wave is a leading diagonal followed by wave which unfolded as a complex zig zag with a b-wave triangle; wave is a strong impulse and wave is a simple zig zag.
Wave
Dischem - Swing high on the radarPrice recently had a pullback after a sold run up and looks to have taken out some longs and perhaps trapped shorts in the process.
Looking for a move now through the swing high @ R31.00
A daily close below major support will change the picture.
Previous post below
DCP: some upside potential?A price action above 3000 supports a bullish trend direction.
Crossing above 3100 triggers the option to increase long exposure.
The target price is set at 3200.
The stop-loss price is set at 2800.
Remains in an inclining channel pattern.
As long as the price action remains above its 23.6% Fibonacc
DCP.JSE Dischem Trend Cloud Study.Dischem has shown a healthy recovery to +-R29.00
The recent Elliott Wave Count is now Ice Blue as it's > 5 and a correction is expected.
I will have to do a FIB Retracement to find where this could be.
Get an Expert's Advice before making any Trade or Investment Decisions.
Smash that Rocket Boost Bu
DCPThursday 09-November-2023, 07h22 Strategy Screen: Dis-Chem Pharmacies (DCP). *A strategy screen is a filter derived from my Tactical Trading Guide which aims to highlight a share's technical position or groups certain shares according to their technical reading on the same time frame. Attached is a
DISCHEM - BreakoutAfter forming a 5-month base which broke out through the 200dma yesterday on the back of an upgrade, the stock looks set to for a decent leg up.
Note: Volume has been increasing into the date of release
Next hurdle up is R28.00, target price R30.50 (likely not in a straight line). Bulls next to k
Our opinion on the current state of DCPDis-Chem Pharmacies (DCP) listed in November 2016 and competes directly with Clicks (CLS) in the pharmaceutical, medicine and beauty products markets. It is a family business run by the Saltzman family who had a controlling stake in the business through a private company, Ivlyn. On 24th August 2021
DCP: SHORT?Price has recently been in a down trend, there have been lower lows and lower highs. The price is below the 200-day moving average.
MACD has crossed below the signal line, momentum to the downside.
Idea: speculative Sell/Short
Stop loss: R26.80
Target: R22.17
Risk/Reward: 1.5
See all ideas
Frequently Asked Questions
The current price of DCP is 3 222 ZAC — it has increased by 0.34% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on JSE exchange DIS-CHEM PHARMACIES LTD stocks are traded under the ticker DCP.
DIS-CHEM PHARMACIES LTD is going to release the next earnings report on May 22, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for DIS-CHEM PHARMACIES LTD has a max estimate of 33 ZAC and a min estimate of 26 ZAC.
DCP earnings for the last quarter are 0.51 ZAC whereas the estimation was 0.54 ZAC which accounts for −6.48% surprise. Estimated earnings for the next quarter are 0.59 ZAC. See more details about DIS-CHEM PHARMACIES LTD earnings.
DIS-CHEM PHARMACIES LTD revenue for the last quarter amounts to 13.30 B ZAC despite the estimated figure of 13.34 B ZAC. In the next quarter revenue is expected to reach 15.39 B ZAC.
Yes, you can track DIS-CHEM PHARMACIES LTD financials in yearly and quarterly reports right on TradingView.
Like other stocks, DCP shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade DIS-CHEM PHARMACIES LTD stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 16, 2024, the company has 20.50 K employees. See our rating of the largest employees — is DIS-CHEM PHARMACIES LTD on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. DIS-CHEM PHARMACIES LTD EBITDA is 2.69 B ZAR, and current EBITDA margin is 8.55%. See more stats in DIS-CHEM PHARMACIES LTD financial statements.